Belgian Museum and Janssen Research & Development, LLC, Honor Transformative Advocacy Work of Indonesian Organization Read more
Today sees the launch of Janssen Therapeutics EMEA, a division of Janssen Pharmaceutica NV, dedicated to bringing the investigational protease inhibitor TMC435 to hepatitis C patients in the EMEA region. Read more
Janssen as received its fifth Galenus Prize in recognition of the medicinal value and enormous success of INCIVO® (telaprevir), a medicinal product for the treatment of Hepatitis C. Read more
Janssen Pharmaceutica S.A. and its sister companies intend to provide consumers with safe and effective drugs, both non-prescription (OTC) and prescription. We are closely monitoring the safety of our products. This is part of an ongoing process of ... Read more
Napoleone Ferrara, M.D., will receive the Johnson & Johnson Dr. Paul Janssen Award for Biomedical Research, including a $100,000 prize, this week during a series of events that celebrate his central role in the discovery of vascular endothelial growth factor (VEGF), the core signaling molecule of angiogenesis. Read more
Discover the different sites of our campus.
View Sustainability Report 2011.
